Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 55(12): 1461-1467, 2021 Dec 06.
Artigo em Chinês | MEDLINE | ID: mdl-34963244

RESUMO

Objective: To analyze the association between high density lipoprotein cholesterol (HDL-C) and the risk of cardiovascular disease mortality. Methods: A total of 71 618 residents aged over 18 years with complete baseline data, who were filed on the health information big data platform of Yinzhou district, Ningbo city, Zhejiang Province from 2009 to 2014, were selected as the research population. The research population were divided into four groups according to the level of HDL-C: low-level group (HDL-C<1.0 mmol/L), intermediate-level group (1.0 mmol/L≤HDL-C<1.5 mmol/L), medium-high-level group (1.5 mmol/L≤HDL-C<2.0 mmol/L) and high-level group (HDL-C≥2.0 mmol/L). Cox proportional hazard model was used to calculate the risk ratio of cardiovascular diseases mortality in different groups. Results: The study population was followed up for a total of 427 989.4 person-years, follow-up time of (5.98±1.04)years. During the follow-up period, there were 799 deaths due to cardiovascular diseases. After adjusting for confounding factors, compared with the medium-high-level group as the reference group, the HR (95%CI) for cardiovascular diseases mortality was 1.43 (1.13-1.82) in the low-level group and 1.22 (1.02-1.46) in the high-level group. Conclusion: The low level of HDL-C (<1.5 mmol/L) is associated with a higher risk of cardiovascular disease deaths. The level of HDL-C can be used as a biological indicator to monitor the development of cardiovascular diseases and guide treatment.


Assuntos
Doenças Cardiovasculares , Adulto , HDL-Colesterol , Humanos , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Fatores de Risco
3.
Beijing Da Xue Xue Bao Yi Xue Ban ; 49(6): 996-1002, 2017 Dec 18.
Artigo em Chinês | MEDLINE | ID: mdl-29263471

RESUMO

OBJECTIVE: To evaluate the efficiency of thoracic endovascular aortic repair (TEVAR) in dealing with abdominal aortic branch malperfusion based on the analysis of aortic computed tomography angiography (CTA) images in pre- and post-TEVAR. METHODS: Retrospective analysis from September 2015 to March 2016 in single institution to 32 patients, diagnosed as Stanford B aortic dissection with abdominal aortic branch malperfusion, CTA images in pre- and post-TEVAR were collected. Based on the aortic branch malperfusion pattern redefined by Nagamine, we identified and characterized branch malperfusion pattern for four abdominal aortic branches (celiac trunk, superior mesenteric artery, bilateral renal artery) in statistical analysis. RESULTS: In the four abdominal aortic branches (total 128 branches), 86 branches (67.2%) expressed with Class I patterns, in which subtype I-b presented with 0.8%, subtype I-c with 5.5%; 14 branches (10.9%) expressed with Class II patterns, in which subtype II-b-1 with 3.9%, subtype II-b-2 with 3.1%; 16 branches (12.5%) expressed with Class III patterns, all with subtype III-a, no subtype III-b and III-c presented. The remaining 12 branches were normal. The 100% successful rate of TEVAR obtained in 32 patients performed. The mean following-up was 4 months. Aortic CTA showed that among the 14 "high-risk" abdominal aortic branch malperfusion, 13 (92.9%) with obvious branch malperfusion in post-TEVAR were observed to improve, and the remaining one branch malperfusion (7.1%) was observed to change from subtype I-b to I-c. CONCLUSION: Few ratios in abdominal aortic branches suffered with obvious malperfusion complicated by Stanford B aortic dissection. For branches with "high-risk" malperfusion pattern, optimal changes were observed in abdominal aortic branch without revascularization in post-TEVAR, as well other branches with non-"high-risk" pattern perfusion were mostly stable in post-TEVAR. It could be of profound benefit to extend branch malperfusion patterns redefined by Nagamine in clinical practice to assess aortic dissection and in further guide for revascularization or not.


Assuntos
Aneurisma da Aorta Torácica/cirurgia , Implante de Prótese Vascular , Procedimentos Endovasculares , Abdome , Dissecção Aórtica , Aorta , Aortografia , Angiografia por Tomografia Computadorizada , Humanos , Estudos Retrospectivos , Resultado do Tratamento
4.
Zhonghua Shao Shang Za Zhi ; 32(10): 606-612, 2016 Oct 20.
Artigo em Chinês | MEDLINE | ID: mdl-27765092

RESUMO

Objective: To explore the acute toxic effect and the cumulative target organ of silver nitrate and nano-silver with two different particle diameters in rats. Methods: Thirty-six adult SD rats were divided into small particle size nano-silver group (SNS), large particle size nano-silver group (LNS), silver nitrate group (SN), and control group (C) according to the random number table, with 9 rats in each group. The rats of the four groups were respectively injected with 10 mg/mL nano-silver solution (particle diameter of 20 nm, prepared by saline) in silver dose of 30 mg/kg by tail vein for once, 10 mg/mL nano-silver solution (particle diameter of 100 nm, prepared by saline) in silver dose of 30 mg/kg, 1.67 mg/mL silver nitrate solution (prepared by glucose solution) in silver dose of 3 mg/kg, and 30 mg/mL polyvinylpyrrolidone solution (prepared by saline) in dose of 90 mg/kg. (1) Toxicity test. The general observation was performed within 14 days after injection, and the deviation between value of body mass before injection and each of that on post injection day (PID) 1, 7, and 14 were respectively recorded. On PID 1, 7, and 14, 3 rats of each group were harvested for determination of serum content of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total protein, and albumin by fully automatic biochemical analyzer. Then the rats were sacrificed immediately, and heart tissue, liver tissue, spleen tissue, lung tissue, kidney tissue, and brain tissue were collected to calculate the organ coefficient. Organ samples with obvious changes in organ coefficient were collected for histopathological observation by HE staining, with 3 samples in each group at each time point. (2) Bio-distribution. The specimens of heart, liver, spleen, lung, and kidney of rats from groups SNS, LNS, and SN were collected for detection of silver content by inductively coupled plasma mass spectrometry, with 3 samples in each group at each time point. Data were processed with analysis of variance of factorial design, LSD test, and Dunnett's T3 test. Results: (1) The general condition of rats in groups C and SN after injection were normal. The state of rats of groups SNS and LNS was poor with black secretion in the eye and other phenomena on PID 1, which recovered from PID 3 on. (2) The deviations between values of body mass before injection and that on PID 14 in rats of groups LNS and SN were significantly decreased as compared with deviation of group C (with P values below 0.01), but deviation of group SNS was not significantly changed (P>0.05). The deviations between values of body mass before injection and each of that on PID 1 and 7 in rats in the other three groups were similar to those in group C (with P values above 0.05). (3) Compared with those in group C, the serum content of total protein of rats in group SN on PID 1 was significantly decreased, and liver coefficient was significantly increased (with P values below 0.05). On PID 1, the serum content of ALT of rats in group LNS was (61.0±8.7) U/L, which was significantly higher than that in group C [(40.0±4.6) U/L, P<0.01]. Compared with those in group C [(126.0±3.5) U/L and 4.05±0.23], the serum content of AST of rats in groups SNS and LNS on PID 1[(249.7±107.2) and (237.0±38.3) U/L] was significantly increased, and liver coefficients (3.50±0.38 and 3.31±0.07) were significantly decreased, with P values below 0.05. Compared with those in group C [(69.2±4.8) U/L and 4.32±0.39], the serum content of AST of rats in groups SNS and LNS on PID 7 [(181.0±51.5) and (167.7±16.5) U/L] was also significantly increased, and liver coefficients (3.55±0.18 and 3.62±0.21) were also significantly decreased, P<0.05 or P<0.01. On PID 14, the four liver biochemical indexes in serum and all organ coefficients of rats in the other three groups were similar to those in group C (with P values above 0.05). (4) The liver of rats in group SN had slight degeneration on PID 1, the liver cells around the central vein of liver of rats in group SNS had slight degeneration on PID 7, and the liver cells got severely eosinophilic degeneration in liver of rats in group LNS on PID 7. There was no significant pathological change in the liver of rats in each group at the rest time points. (5) The silver content of lung and kidney in rats of group SNS on PID 1, that of spleen and kidney in rats of group LNS on PID 1, and that of heart and kidney in rats of groups LNS and SNS on PID 7 was significantly less than that of group SN (with P values below 0.05). The silver content of liver and spleen in rats of group SNS on PID 14 was significantly more than that of group SN (with P values below 0.05). Compared with that of group SN, the silver content of lung on PID 1 and liver on PID 7 in rats of group LNS was significantly increased (with P values below 0.05). On PID 14, there was no significant change in the silver content of all organs of rats between group SN and group LNS (with P values above 0.05). The silver content of heart, lung, and kidney on PID 1 and heart on PID 7 in rats of group LNS was significantly more than that of group SNS (with P values below 0.05). On PID 14, the silver content of each organ of rats in group SNS was close to that in group LNS (with P values above 0.05). Conclusions: Silver nitrate and nano-silver with two different particle diameters have a short acute toxic effect on the liver of rats, and the liver has certain ability of self-healing. Nano-silver is mainly accumulated in the liver. The distribution of nano-silver with large particle diameter in organs is more widely than that of nano-silver with small particle diameter.


Assuntos
Nanopartículas/toxicidade , Nitrato de Prata/toxicidade , Alanina Transaminase , Animais , Queimaduras , Hepatócitos , Rim , Fígado , Pulmão , Ratos , Ratos Sprague-Dawley , Prata , Baço
5.
Zhonghua Xin Xue Guan Bing Za Zhi ; 44(8): 691-5, 2016 Aug 24.
Artigo em Chinês | MEDLINE | ID: mdl-27545128

RESUMO

OBJECTIVE: To evaluate the efficacy of simultaneous thoracic endovascular aortic repair (TEVAR) and endovascular aneurysm repair (EVAR) on abdominal aortic aneurysm (AAA) patients complicating acute aortic syndrome (AAS). METHODS: Data of 17 patients (16 men, mean age (65.2±6.9) years old) , who underwent simultaneous TEVAR and EVAR between September 2010 and June 2015 in Beijing Anzhen Hospital, were retrospectively reviewed.All patients were diagnosed with concomitant AAA and AAS by preoperative CTA.All abdominal aortic lesions were AAA and all thoracic aortic lesions were AAS.Under local anesthesia, simultaneous TEVAR and EVAR were performed and emergent simultaneous endovascular repair was performed in 2 patients.Follow up was made at 1 month, 3 months, 6 months, and yearly after the procedure.Procedure success rate, procedure related complications were evaluated. RESULTS: Procedure was successful in all patients.The length of thoracic coverage was (21.0±4.6) cm.The operation time was 150(120, 170) min, and the hospitalization time was 7 (6, 12) d. After a mean of 27.0(5.5, 44.5) months follow up, there were no acute cardiopulmonary complications and contrast induced nephropathy.One patient developed spinal cord ischemia and resolved after treatment.One patient was died for aneurysm rupture at 6 months post operation.One patient developed type Ⅰb endoleak for expansion of right iliac artery at 9 months post operation and was successfully sealed by iliac stent-graft extension. CONCLUSIONS: Combined TEVAR and EVAR can be performed successfully in patients with AAA complicating AAS.When anatomically feasible, simultaneous TEVAR and EVAR can be considered as a effective and safe therapy alternative to patients with multilevel aortic diseases.


Assuntos
Aneurisma da Aorta Abdominal/cirurgia , Procedimentos Endovasculares , Idoso , Aorta Abdominal/cirurgia , Aorta Torácica/cirurgia , Implante de Prótese Vascular , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Stents , Fatores de Tempo , Resultado do Tratamento
6.
Neoplasma ; 60(4): 364-72, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23581408

RESUMO

Colorectal cancer (CRC), one of the most common human malignancies, is a major public health problem in the developed world. Capsaicin, widely used as a food additive and as an analgesic agent, is a major pungent ingredient of red pepper. Though capsaicin-induced apoptosis was previously reported in cancer cells, relatively little is known about the impact of capsaicin on other aspect of cancer cell behavior. In this study, we demonstrated that treatment with high-concentration of capsaicin (≥ 200 µM for SW480 and CT-26 cell lines; ≥ 25 µM for HCT116 cell line) inhibited CRC cell proliferation in a dose-dependent manner. In spite of no anti-proliferative effect, notably, low-concentration of capsaicin (100 µM for SW480 and CT-26 cell lines; 12.5 µM for HCT116 cell line) enhanced both migratory and invasive capability of these cells, which was validated by both in vitro and in vivo model. Further, we showed that 100 µM capsaicin induced epithelial-to-mesenchymal (EMT), up-regulated expression of MMP-2 and MMP-9, and activated Akt/mTOR and STAT-3 pathways in SW480 cells. Finally, we showed that capsaicin-induced metastasis of CRC cells was mediated by modulating reactive oxygen species (ROS) production. Our findings are considered a significant step toward a better understanding of capsaicin-associated regulatory network on CRC cells.


Assuntos
Capsaicina/farmacologia , Neoplasias Colorretais/patologia , Proteínas Proto-Oncogênicas c-akt/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Fator de Transcrição STAT3/fisiologia , Transdução de Sinais/efeitos dos fármacos , Serina-Treonina Quinases TOR/fisiologia , Animais , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Humanos , Metaloproteinase 2 da Matriz/análise , Metaloproteinase 9 da Matriz/análise , Camundongos , Camundongos Endogâmicos BALB C , Invasividade Neoplásica , Metástase Neoplásica , Transdução de Sinais/fisiologia
8.
Clin Exp Dermatol ; 33(2): 171-5, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18201262

RESUMO

BACKGROUND: The precise mechanism of asiaticoside in molecular and gene expression levels of Smad protein and mRNA still remains unknown. We hypothesised that asiaticoside might inhibit the formation of hypertrophic scarring by affecting the expression of Smad protein and interfering with the Smad signalling pathway. AIMS: To investigate the effects of asiaticoside on the expression of Smad protein by hypertrophic scar fibroblasts (HSFs) and to clarify the mechanism of asiaticoside in scar treatment. METHODS: Normal skin fibroblasts and HSFs were exposed to various concentrations of asiaticoside in serum-free medium for 72 h, then immunocytochemistry was used to examine the localization and expression of phosphorylated Smad2 and Smad7. The expression of Smad protein was studied both at the transcriptional and post-transcriptional levels, using conventional reverse transcription PCR and Western blotting. RESULTS: Asiaticoside markedly enhanced the expression of inhibitory Smad7, but it had no effect on the expression of Smad2. Further study revealed that asiaticoside could induce Smad7 to enter the cytoplasm from the nucleus. CONCLUSIONS: Asiaticoside inhibits scarring probably by enhancing the expression of inhibitory Smad7, and is a potential treatment for scarring.


Assuntos
Anti-Infecciosos/uso terapêutico , Cicatriz Hipertrófica/prevenção & controle , Fibroblastos/efeitos dos fármacos , Proteína Smad2/metabolismo , Proteína Smad7/metabolismo , Triterpenos/uso terapêutico , Cicatriz Hipertrófica/metabolismo , Cicatriz Hipertrófica/patologia , Feminino , Expressão Gênica , Regulação da Expressão Gênica , Humanos , Masculino , Transdução de Sinais/efeitos dos fármacos , Transcrição Gênica/efeitos dos fármacos , Fator de Crescimento Transformador beta/efeitos adversos
9.
J Asian Nat Prod Res ; 8(8): 719-22, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17145660

RESUMO

Two new indole alkaloids, naucleactonin A and B, along with two known compounds, naucleficine and nauclefidine, were isolated from the bark and wood of Naucleaofficinalis, which has been used as an anti-inflammatory and anti-bacterial agent in folk medicine. Their chemical structures were elucidated by the spectral data, especially 1D and 2D NMR experiments.


Assuntos
Alcaloides Indólicos/química , Componentes Aéreos da Planta/química , Plantas Medicinais/química , Rubiaceae/química , China , Cromatografia , Alcaloides Indólicos/isolamento & purificação , Espectroscopia de Ressonância Magnética , Estrutura Molecular
10.
Nat Prod Res ; 20(13): 1237-40, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17127515

RESUMO

Two new xanthones, 1,6-dihydroxyisojacereubin-5-O-beta-D-glucoside (1) and 3,6,7-tri-hydroxy-1-methoxy-xanthone (2), were isolated from Hypericum japonicum. The structural elucidation of the isolated compounds were primarily based on HREIMS, EIMS, UV, IR, 1D-, and 2D-NMR analyses, including COSY, HMQC, HMBC, and NOESY correlations.


Assuntos
Hypericum/química , Extratos Vegetais/isolamento & purificação , Xantonas/isolamento & purificação , China , Espectrometria de Massas , Ressonância Magnética Nuclear Biomolecular , Rotação Ocular , Extratos Vegetais/química , Espectrofotometria Infravermelho , Espectrofotometria Ultravioleta , Xantonas/química
11.
J Asian Nat Prod Res ; 8(5): 401-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16864455

RESUMO

Three new flavonol glycosides and a new xanthone were isolated from Polygala japonica HOUTT. with eight known compounds. Their structures were identified as 1,7-dihydroxy-3,4-dimethoxy-xanthone (1), kaempferol-7,4'-dimethyl ether (2), physcion (3), guazijinxanthone (4), rhamnetin (5), polygalin A (6), 3,5,7-trihydroxy-4'-methoxy-flavone-3-O-beta-d-galactopyranoside (7), 3,5,3'-trihydoxy-7,4'-dimethoxy-flavone-3-O-beta-d-galactopyranoside (8), 3,5,3',4'-tetrahydroxy-7-methoxy-flavone-3-O-beta-d-galactopyranoside (9), 3,5,3',4'-tetrahydroxy-7-methoxy-flavone-3-O-beta-d-glucopyranoside (10), polygalin B (11), polygalin C (12). Among them, compound 4 is a new xanthone, and 6, 11 and 12 are new flavonol glycosides. Compounds 1, 4, 7 and 8 were tested for cytotoxic activity with MTT assays on five human tumor cell lines, K562, A549, PC-3M, HCT-8 and SHG-44. Compound 4 showed cytotoxic activity against all the five cell lines.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Fitoterapia , Extratos Vegetais/farmacologia , Polygala , Antineoplásicos Fitogênicos/administração & dosagem , Antineoplásicos Fitogênicos/uso terapêutico , Linhagem Celular Tumoral/efeitos dos fármacos , Flavonas/administração & dosagem , Flavonas/farmacologia , Flavonas/uso terapêutico , Glicosídeos/administração & dosagem , Glicosídeos/farmacologia , Glicosídeos/uso terapêutico , Humanos , Concentração Inibidora 50 , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico , Xantonas/administração & dosagem , Xantonas/farmacologia , Xantonas/uso terapêutico
12.
Exp Mol Med ; 33(2): 59-63, 2001 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-11460882

RESUMO

A possible role of hepatocyte nuclear factor 1 (HNF1) or HNF3, a predominant trans-acting factors of hepatic or pancreatic beta-cells, was examined on the tissue specific interdependent expression of glucokinase (GK) in liver, H4IIE, HepG2, HIT-T15 and MIN6 cell line. The tissues or cell lines known to express GK showed abundant levels of HNF1 and HNF3 mRNA as observed in liver, H4IIE, HepG2, HIT-T15 and MIN6 cells, whereas they were not detected in brain, heart, NIH 3T3, HeLa cells. The promoter of glucokinase contains several HNF3 consensus sequences and are well conserved in human, mouse and rat. Transfection of the glucokinase promotor linked with luciferase reporter to liver or pancreatic beta cell lines showed high interacting activities with HNF1 and HNF3, whereas minimal activities were detected in the cells expressing very low levels of HNFs. The binding of HNF1 or HNF3 to the GK promoter genes was confirmed by electrophoretic mobility shift assay (EMSA). From these data, we propose that the expression of HNF1 and/or HNF3 may, in part, contribute to the tissue specific expression of GK


Assuntos
Proteínas de Ligação a DNA/fisiologia , Glucoquinase/biossíntese , Glucoquinase/genética , Proteínas Nucleares/fisiologia , Fatores de Transcrição/fisiologia , Células 3T3 , Animais , Northern Blotting , Linhagem Celular , Núcleo Celular/metabolismo , Células Cultivadas , Proteínas de Ligação a DNA/genética , Genes Reporter , Células HeLa , Fator 1 Nuclear de Hepatócito , Fator 1-alfa Nuclear de Hepatócito , Fator 1-beta Nuclear de Hepatócito , Fator 3-beta Nuclear de Hepatócito , Humanos , Fígado/metabolismo , Luciferases/metabolismo , Camundongos , Modelos Genéticos , Proteínas Nucleares/genética , Plasmídeos/metabolismo , Regiões Promotoras Genéticas , Ligação Proteica , Ratos , Distribuição Tecidual , Fatores de Transcrição/genética , Transcrição Gênica , Transfecção
13.
Zhongguo Zhong Yao Za Zhi ; 23(7): 424-6, 448- inside back cover, 1998 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-11601354

RESUMO

OBJECTIVE: To investigate the inhibitory effect of Boschniakia rossica(BR) on hepatocarcinogenesis in rats. METHOD: Based on immunohistochemistry techniques, the expression of placental form glutathione S-transferase(GST-P), mutant p53 and p21 protein were investigated in hepatic preneoplastic lesions induced by Solt-Farber protocol in the liver of rats that had been treated with the above method, administered with BR extract and of control group. RESULT: The extract of BR(500 mg/kg) has inhibitory effect on the formation of diethylnitrosamine-induced GST-P-positive foci in F344 rat and the expression of mutant p53 and p21 protein was lower than that of hepatic preneoplastic lesions, and the increasing gamma-glutamyltranspeptidase(gamma-GT) activity in rat liver treated with Solt-Farber protocol was decreased by the extract of BR. CONCLUSION: These results indicate that BR has inhibitory effect on DEN induced hepatic preneoplastic lesions in F344 rat.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Neoplasias Hepáticas Experimentais/prevenção & controle , Magnoliopsida/química , Plantas Medicinais/química , Lesões Pré-Cancerosas/prevenção & controle , Animais , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/metabolismo , Dietilnitrosamina , Glutationa Transferase/metabolismo , Fígado/metabolismo , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/metabolismo , Masculino , Lesões Pré-Cancerosas/induzido quimicamente , Lesões Pré-Cancerosas/metabolismo , Ratos , Ratos Endogâmicos F344 , Proteína Supressora de Tumor p53/metabolismo
14.
Gynecol Oncol ; 65(2): 319-24, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9159345

RESUMO

Chromosome 9 abnormalities have been found in primary tumors and cell lines from human gynecologic malignancy. Alterations of p16INK4 and p15INK4B genes mapped on the band p21 of chromosome 9 have been detected in various human tumors, but the role of these genes as tumor suppressors in vivo appear to be dependent on tumor type. Polymerase chain reaction (PCR)-based analysis was performed to search for lesions of these genes in 202 primary gynecologic malignancies. Homozygous deletions of p16INK4 were detected in 7 of 128 (5%) cervical, 1 of 41 (2%) endometrial, 2 of 27 (7%) ovarian, and 3 of 6 (50%) vulvar carcinomas, while homozygous deletions of p15INK4B were detected in 19 of 128 (15%) cervical, 1 of 41 (2%) endometrial, 9 of 27 (33%) ovarian, and 3 of 6 (50%) vulvar carcinomas, respectively. No mutations were found in exon 2 of p16INK4 from 161 cases of gynecologic malignancy without deletion of p16INK4. All 3 cases of vulvar carcinoma showing homozygous deletions of p16INK4 and p15INK4B were at advanced clinical stage (stage III-IV), while all 7 cases of cervical carcinoma and 2 cases of ovarian carcinoma showing homozygous deletion of p16INK4 were at early stage (stage I-II). The results indicate that homozygous deletions of p16INK4 and/or p15INK4B genes may play a role in a subset of primary gynecologic malignancy.


Assuntos
Proteínas de Transporte/genética , Proteínas de Ciclo Celular , Genes Supressores de Tumor/genética , Neoplasias dos Genitais Femininos/genética , Mutação/genética , Proteínas Supressoras de Tumor , Inibidor de Quinase Dependente de Ciclina p15 , Inibidor p16 de Quinase Dependente de Ciclina , DNA de Neoplasias/análise , Feminino , Humanos , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita Simples
15.
Sheng Li Xue Bao ; 43(3): 280-5, 1991 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-1788563

RESUMO

The present study was undertaken to analyze whether the glucocorticoid (GC) effect was region specific in the brain. Na-cortisol-succinate (HC) was applied iontophoretically to cerebral cortex (CX), hippocampus (HPC) and PVN respectively and the effect on unit discharge rate in these three brain areas were compared. In cerebral cortex, the percentage of responsive neurons was only 8% (4/50), which was significantly lower than those in HPC (10/36, 27.8%) and PVN (9/35, 25.7%). The difference in the occurrence is paralleled with the known distribution of traditional GC cytosolic receptors in the brain. In all the three brain areas studied the main response to GC was inhibitory and the latencies of the responses were 9.6 +/- 6.5, 22.7 +/- 24.0, and 14.5 +/- 11.5 s and the durations of the after-effect were 74.8 +/- 66.5 (n = 4), 24.2 +/- 14.5 (n = 6) and 21.0 +/- 10.5 s (n = 9) respectively. The shortness of the latencies once again suggests that the mechanism involved is non-genomic. It is interest to note that in some HPC neurons the after-effect lasted for 1758 +/- 2148 s (n = 4). The results show that the rapid effect of GC on neurons is different in the three brain areas studied in regarding to the occurrence of responsive neurons and the duration of the after-effects.


Assuntos
Encéfalo/efeitos dos fármacos , Hidrocortisona/análogos & derivados , Animais , Encéfalo/fisiologia , Córtex Cerebral/efeitos dos fármacos , Eletrofisiologia , Hipocampo/efeitos dos fármacos , Hidrocortisona/farmacologia , Iontoforese , Masculino , Neurônios/efeitos dos fármacos , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Receptores de Glucocorticoides/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...